Clinical Trial Update: Golimumab for Adherence in Rheumatoid Arthritis

View source ↗

Summary

Completed clinical trial update investigating golimumab for adherence in rheumatoid arthritis, sponsored by Janssen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Janssen Inc. | Conditions: Arthritis, Rheumatoid | Status: COMPLETED